{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:09:31Z","timestamp":1788170971058,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.carrev.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T10:08:57Z","timestamp":1531908537000},"page":"328-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker"],"prefix":"10.1016","volume":"20","author":[{"given":"Brett","family":"Oestreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcuk","family":"Adabag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Helmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Raveendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetris","family":"Yannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timinder","family":"Biring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.carrev.2018.07.012_bb0005","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jacc.2016.11.033","article-title":"2016 annual report of The Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapy registry","volume":"69","author":"Grover","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.07.012_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2017.04.053","article-title":"Temporal trends in Transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI","volume":"70","author":"Auffret","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.carrev.2018.07.012_bb0015","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jcin.2016.07.026","article-title":"Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the US Society of Thoracic Surgeons\/American College of Cardiology TVT registry","volume":"9","author":"Fadahunsi","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.carrev.2018.07.012_bb0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcin.2017.10.032","article-title":"Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement","volume":"11","author":"Chamandi","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2018.07.012_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacc.2014.04.033","article-title":"Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis","volume":"64","author":"Siontis","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2018.07.012_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.15420\/AER.2015.04.02.81","article-title":"Mechanisms of heart block after transcatheter aortic valve replacement \u2014 cardiac anatomy, clinical predictors and mechanical factors that contribute to permanent pacemaker implantation","volume":"4","author":"Young Lee","year":"2015","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"1 Pt A","key":"10.1016\/j.carrev.2018.07.012_bb0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcin.2014.07.022","article-title":"Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of Aortic Transcatheter Valves) trial and registry","volume":"8","author":"Nazif","year":"2015","journal-title":"J Am Coll Cardiol Interv"},{"issue":"5","key":"10.1016\/j.carrev.2018.07.012_bb0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcin.2012.03.012","article-title":"Pathology of transcatheter valve therapy","volume":"5","author":"Nietlispach","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.carrev.2018.07.012_bb0045","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.jcin.2016.08.034","article-title":"Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3","volume":"9","author":"Mauri","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.07.012_bb0050","article-title":"Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve","author":"Oestreich","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2018.07.012_bb0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/en.2012-2045","article-title":"New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation","volume":"154","author":"Vandevyver","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.carrev.2018.07.012_bb0060","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.carrev.2017.03.009","article-title":"Conduction disturbances after TAVR: electrophysiological studies and pacemaker dependency","volume":"18","author":"Makki","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2018.07.012_bb0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2459\/JCM.0b013e32832401c2","article-title":"Is steroid therapy enough to reverse complete atrioventricular block after percutaneous perimembranous ventricular septal defect closure?","volume":"10","author":"Butera","year":"2009","journal-title":"J Cariovasc Med"},{"issue":"3","key":"10.1016\/j.carrev.2018.07.012_bb0070","first-page":"436","article-title":"Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect","volume":"66","author":"Yip","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2018.07.012_bb0075","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/hrt.2005.084988","article-title":"Atrioventricular block after transcatheter closure of perimembranous ventricular septal defects","volume":"92","author":"Walsh","year":"2006","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.carrev.2018.07.012_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/1755-5922.12202","article-title":"Steroid therapy and conduction disturbances after transcatheter aortic valve implantation","volume":"34","author":"Havakuk","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.carrev.2018.07.012_bb0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and nongenomic effects of glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"3","key":"10.1016\/j.carrev.2018.07.012_bb0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcin.2017.10.032","article-title":"Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement","volume":"11","author":"Chamandi","year":"2018","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918303117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918303117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:15:36Z","timestamp":1761560136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838918303117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1553838918303117"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2018.07.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}